Cargando…

Synergy between Photodynamic Therapy and Dactinomycin Chemotherapy in 2D and 3D Ovarian Cancer Cell Cultures

In this study we explored the efficacy of combining low dose photodynamic therapy using a porphyrin photosensitiser and dactinomycin, a commonly used chemotherapeutic agent. The studies were carried out on compressed collagen 3D constructs of two human ovarian cancer cell lines (SKOV3 and HEY) versu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mohammad Hadi, Layla, Yaghini, Elnaz, MacRobert, Alexander J., Loizidou, Marilena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7247344/ https://www.ncbi.nlm.nih.gov/pubmed/32366058 http://dx.doi.org/10.3390/ijms21093203

Ejemplares similares

Treatment of 3D In Vitro Tumoroids of Ovarian Cancer Using Photochemical Internalisation as a Drug Delivery Method
por: Mohammad Hadi, Layla, et al.
Publicado: (2023)

Codelivery of a cytotoxin and photosensitiser via a liposomal nanocarrier: a novel strategy for light-triggered cytosolic release
por: Yaghini, Elnaz, et al.
Publicado: (2018)

Endolysosomal targeting of a clinical chlorin photosensitiser for light-triggered delivery of nano-sized medicines
por: Yaghini, Elnaz, et al.
Publicado: (2017)

One-Step Aqueous Synthesis of Anionic and Cationic AgInS(2) Quantum Dots and Their Utility in Improving the Efficacy of ALA-Based Photodynamic Therapy
por: Hashemkhani, Mahshid, et al.
Publicado: (2022)

Flexible synthesis of cationic peptide–porphyrin derivatives for light-triggered drug delivery and photodynamic therapy
por: Dondi, R., et al.
Publicado: (2016)

Peripheral neural cell sensitivity to mTHPC-mediated photodynamic therapy in a 3D in vitro model
por: Wright, K E, et al.
Publicado: (2009)

Dactinomycin/vincristine: Various toxicities: case report
Publicado: (2021)

Persistent gestational trophoblastic disease: results of MEA (methotrexate, etoposide and dactinomycin) as first-line chemotherapy in high risk disease and EA (etoposide and dactinomycin) as second-line therapy for low risk disease
por: Dobson, L S, et al.
Publicado: (2000)

The intracellular redox environment modulates the cytotoxic efficacy of single and combination chemotherapy in breast cancer cells using photochemical internalisation
por: Adigbli, Derick K., et al.
Publicado: (2019)

Organic Nanodelivery Systems as a New Platform in the Management of Breast Cancer: A Comprehensive Review from Preclinical to Clinical Studies
por: Rafik, Salma T., et al.
Publicado: (2023)

In vivo biodistribution and toxicology studies of cadmium-free indium-based quantum dot nanoparticles in a rat model
por: Yaghini, Elnaz, et al.
Publicado: (2018)

Dactinomycin-induced Hepatic Sinusoidal Obstruction Syndrome Responding to Treatment with N-acetylcysteine
por: Lee, Anselm Chi-wai, et al.
Publicado: (2011)

Inhibition of transcription by dactinomycin reveals a new characteristic of immunogenic cell stress
por: Humeau, Juliette, et al.
Publicado: (2020)

Enhancing the efficacy of cytotoxic agents for cancer therapy using photochemical internalisation
por: Martinez de Pinillos Bayona, Alejandra, et al.
Publicado: (2016)

In vivo biodistribution studies and ex vivo lymph node imaging using heavy metal-free quantum dots
por: Yaghini, Elnaz, et al.
Publicado: (2016)

Synergistic interactions of cadmium-free quantum dots embedded in a photosensitised polymer surface: efficient killing of multidrug-resistant strains at low ambient light levels
por: Owusu, Ethel G. A., et al.
Publicado: (2020)

Recurrent Metastatic Choriocarcinoma Responsive to Etoposide and Cisplatin with Etoposide, Methotrexate, and Dactinomycin: A Case Report
por: Das, Sunil Kumar, et al.
Publicado: (2022)

Photodynamic and Photothermal Therapies: Synergy Opportunities for Nanomedicine
por: Overchuk, Marta, et al.
Publicado: (2023)

Dactinomycin induces complete remission associated with nucleolar stress response in relapsed/refractory NPM1-mutated AML
por: Gionfriddo, Ilaria, et al.
Publicado: (2021)

Photodynamic Therapy in Primary Breast Cancer
por: Banerjee, Shramana M., et al.
Publicado: (2020)

The significance of the nature of the photosensitizer for photodynamic therapy: quantitative and biological studies in the colon.
por: Barr, H., et al.
Publicado: (1990)

Oral versus intravenous administration of 5-aminolaevulinic acid for photodynamic therapy.
por: Loh, C. S., et al.
Publicado: (1993)

Population pharmacokinetic modelling of indium-based quantum dot nanoparticles: preclinical in vivo studies
por: Yaghini, Elnaz, et al.
Publicado: (2021)

Photodynamic therapy in the normal rat colon with phthalocyanine sensitisation.
por: Barr, H., et al.
Publicado: (1987)

Photodynamic therapy using 5-aminolaevulinic acid for experimental pancreatic cancer--prolonged animal survival.
por: Regula, J., et al.
Publicado: (1994)

Photochemical internalisation of chemotherapy potentiates killing of multidrug-resistant breast and bladder cancer cells
por: Adigbli, D K, et al.
Publicado: (2007)

Synergy of Chemo- and Photodynamic Therapies with C(60) Fullerene-Doxorubicin Nanocomplex
por: Grebinyk, Anna, et al.
Publicado: (2019)

Porphyrin synthesis from ALA derivatives for photodynamic therapy. In vitro and in vivo studies
por: Perotti, C, et al.
Publicado: (2004)

Photodynamic therapy with phthalocyanine sensitisation: quantitative studies in a transplantable rat fibrosarcoma.
por: Tralau, C. J., et al.
Publicado: (1987)

Photodynamic therapy on the normal rabbit larynx with phthalocyanine and 5-aminolaevulinic acid induced protoporphyrin IX photosensitisation.
por: Kleemann, D., et al.
Publicado: (1996)

Risk factors for second‐line dactinomycin failure after methotrexate treatment for low‐risk gestational trophoblastic neoplasia: a retrospective study
por: Hoeijmakers, YM, et al.
Publicado: (2020)

Serum human chorionic gonadotropin ratios for the detection of etoposide, methotrexate, dactinomycin, cyclophosphamide, and vincristine resistance in high‐risk gestational trophoblastic neoplasia
por: Sirimusika, Nathapol, et al.
Publicado: (2022)

Cancer cells grown in 3D under fluid flow exhibit an aggressive phenotype and reduced responsiveness to the anti-cancer treatment doxorubicin
por: Azimi, Tayebeh, et al.
Publicado: (2020)

Fluorescence distribution and photodynamic effect of ALA-induced PP IX in the DMH rat colonic tumour model.
por: Bedwell, J., et al.
Publicado: (1992)

Correlation of real-time haemoglobin oxygen saturation monitoring during photodynamic therapy with microvascular effects and tissue necrosis in normal rat liver
por: Woodhams, J H, et al.
Publicado: (2004)

Photodynamic therapy of normal rat arteries after photosensitisation using disulphonated aluminium phthalocyanine and 5-aminolaevulinic acid.
por: Grant, W. E., et al.
Publicado: (1994)

The challenge of ovarian tissue culture: 2D versus 3D culture
por: Pais, Ana Sofia, et al.
Publicado: (2021)

A scintillating nanoplatform with upconversion function for the synergy of radiation and photodynamic therapies for deep tumors
por: Feng, Yansong, et al.
Publicado: (2021)

The use of nanomaterials in advancing photodynamic therapy (PDT) for deep-seated tumors and synergy with radiotherapy
por: Dinakaran, Deepak, et al.
Publicado: (2023)

Photodynamic therapy of the normal rat stomach: a comparative study between di-sulphonated aluminium phthalocyanine and 5-aminolaevulinic acid.
por: Loh, C. S., et al.
Publicado: (1992)

Cannot write session to /tmp/vufind_sessions/sess_3oi99fa529jjokcfkge2414nvm